Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study

D. A. Mahler, V. Brunel, T. White, V. Alagappan, H. Chen, K. Kulich, N. Gallagher, D. Banerji (Hanover, East Hanover, United States Of America; Lyon, France; Basel, Switzerland; Horsham, United Kingdom)

Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders

Session: Novel pharmacological findings in the management of respiratory disorders
Session type: Thematic Poster Session
Number: 718

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. A. Mahler, V. Brunel, T. White, V. Alagappan, H. Chen, K. Kulich, N. Gallagher, D. Banerji (Hanover, East Hanover, United States Of America; Lyon, France; Basel, Switzerland; Horsham, United Kingdom). Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study. Eur Respir J 2013; 42: Suppl. 57, 718

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Testing the validity of a self-administered questionnaire version of the transition dyspnea index in COPD patients Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016
Responsiveness of dyspnea through the pulmonary function status and dyspnea questionnaire – Modified version (PFSDQ-M) post different training programs in patients with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013
Multidimensional evaluation of dyspnea in COPD: An observational field-study Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
The relationship between dyspnea and detection of depression in COPD patients (pts) Source: International Congress 2015 – Different data in COPD Year: 2015
Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016
CAT (COPD assessment test) in the initial assessment for pulmonary rehabilitation program Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013
Correlation between COPD assessment test (CAT) and mMRC dyspnea scale in evaluationg COPD symptoms Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019
Validtiy and usability testing of the Fitbit pedometer in patients with COPD Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015
Development of a Barthel index based on dyspnea for patients with respiratory diseases Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016
Benefits of the LAMA/LABA glycopyrronium (GP)/formoterol (FF) MDI FDC, delivered using a novel MDI co-suspension technology (GFF MDI), increase with baseline symptom severity in COPD patients (pts) Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Comparison of modified medical research council scale and COPD assessment test in subjects with COPD Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Agreement between patient-reported and chart documented outcomes: Case study in COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Comparing the chronic respiratory questionnaire-self report (CRQ-SR) and the breathing problems questionnaire (short version) (BPQ-SV) as a quality of life outcome measure for pulmonary rehabilitation (PR) Source: Annual Congress 2007 - Rehabilitation: measuring, monitoring and maintenance Year: 2007
A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395) Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014
Inhaler competence and patient satisfaction with a DPI; results of two real-life studies in asthma and COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013